Cargando…
Parkinson's disease patients may have higher rates of Covid-19 mortality in Iran
BACKGROUND: Parkinson's disease (PD) patients may be at increased risk of Covid-19 mortality due to the nature of their disease or underlying conditions. METHOD: The information of 12,909 Covid-19 patients who were hospitalized during the last eleven months were collected from the data deposito...
Autores principales: | Salari, Mehri, Etemadifar, Masoud, Ashrafi, Farzad, Ommi, Davood, Aminzade, Zahra, Tehrani Fateh, Sepand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264275/ https://www.ncbi.nlm.nih.gov/pubmed/34256334 http://dx.doi.org/10.1016/j.parkreldis.2021.07.002 |
Ejemplares similares
-
Limited access to health care in patients with atypical parkinsonism during COVID-19 era may lead to higher mortality
por: Salari, Mehri, et al.
Publicado: (2022) -
Prevalence of coronavirus disease 2019 in patients with neuromyelitis optica in Isfahan, Iran, and a review on recent reports and literature
por: Etemadifar, Masoud, et al.
Publicado: (2021) -
Deep brain stimulation of anteromedial globus pallidus internus improved OCD rather than tics in a Gilles de la Tourette syndrome patient
por: Aminzade, Zahra, et al.
Publicado: (2021) -
Case series: New‐onset freezing of gait in combined use of deep brain stimulation and Levodopa
por: Salari, Mehri, et al.
Publicado: (2021) -
Covid-19 in Parkinson's Disease treated by drugs or brain stimulation
por: Salari, M., et al.
Publicado: (2021)